Article
HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
Pain practice : the official journal of World Institute of Pain - 1 Mar 2012
Kulkantrakorn Kongkiat, Tassaneeyakul Wichittra, Tiamkao Somsak, Jantararoungtong Thawinee, Prabmechai Napat, Vannaprasaht Suda, Chumworathayi Pansu, Chen Pei, Sritipsukho Paskorn
Abstract excerpt
BACKGROUND: Carbamazepine (CBZ) is one of the standard pharmacological treatments for neuropathic pain. However, its serious adverse drug reactions include Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Recently, HLA-B*1502 allele was implicated as a genetic marker of CBZ-induced SJS/TEN in some Asian epilepsy populations. METHODS: This is a case control study to describe the clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
